» Authors » Andrew M McDonald

Andrew M McDonald

Explore the profile of Andrew M McDonald including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 63
Citations 295
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Siwakoti K, Dalton A, Maas J, McDonald A, Marcrom S, Cardan R, et al.
Int J Part Ther . 2025 Mar; 15:100740. PMID: 40061450
Purpose: Robustness evaluation is critical for proton beam therapy (PBT) planning, but ideal robustness criteria are not clearly defined. Here, we compared robustness of PBT plans to published intensity-modulated radiation...
2.
Siwakoti K, Nabell L, McDonald A, Williams G
J Geriatr Oncol . 2024 Jun; 15(7):101818. PMID: 38942691
No abstract available.
3.
McDonald A, Murdaugh D, Heinzman K, Cardan R, Jacob J, Fiveash J, et al.
J Neurosurg . 2024 Apr; 141(3):634-641. PMID: 38669700
Objective: Radiation therapy (RT) is used selectively for patients with low-grade glioma (LGG) given the concerns for potential cognitive effects in survivors, but prior cognitive outcome studies among LGG survivors...
4.
Faro J, Dressler E, Kittel C, Beeler D, Bluethmann S, Sohl S, et al.
JNCI Cancer Spectr . 2024 Jan; 8(1). PMID: 38268476
Background: National cancer organizations recommend provision of nutrition, physical activity, and mental health supportive services to cancer survivors. However, the availability of these services across diverse community oncology settings remains...
5.
Murdaugh D, Milner D, Cardenas C, Heinzman K, Cooper C, Tabb J, et al.
Radiother Oncol . 2023 Dec; 191:110068. PMID: 38142935
Background: Radiation therapy (RT) for locally advanced head and neck cancer (HNC) often exposes subcortical brain structures to radiation. We performed this study to assess region-specific brain volumetrics in a...
6.
Maas J, McDonald A, Cardan R, Snider J, Fiveash J, Kole A
Pract Radiat Oncol . 2023 Sep; 14(1):e68-e74. PMID: 37748679
Purpose: Robustness evaluation is increasingly used in particle therapy planning to assess clinical target volume (CTV) coverage in the setting of setup and range uncertainty. However, no clear standard exists...
7.
Pogue J, Cardenas C, Harms J, Soike M, Kole A, Schneider C, et al.
Adv Radiat Oncol . 2023 Jul; 8(6):101292. PMID: 37457825
Purpose: Currently, there is insufficient guidance for standard fractionation lung planning using the Varian Ethos adaptive treatment planning system and its unique intelligent optimization engine. Here, we address this gap...
8.
Brown M, Marcrom S, Patel M, Popple R, Travis R, McDonald A, et al.
Neurosurgery . 2023 Jul; 93(6):1313-1318. PMID: 37449861
Background And Objectives: There is wide variation in treatment planning strategy for central nervous system (CNS) stereotactic radiosurgery. We sought to understand what relationships exist between intratumor maximum dose and...
9.
Maas J, Dobelbower M, Yang E, Clark G, Jacob R, Kim R, et al.
Pract Radiat Oncol . 2023 Jun; 13(5):466-474. PMID: 37268193
Purpose: Stereotactic body radiation therapy (SBRT) is increasingly used as a definitive treatment option for patients with prostate adenocarcinoma. The aim of this study was to assess the late toxicity,...
10.
Jones J, Soike M, Boggs D, Fiveash J, Cardan R, Bonner J, et al.
Adv Radiat Oncol . 2023 May; 8(4):101218. PMID: 37124317
Purpose: The aim of this work was to describe the design and implementation of a more robust workflow for communicating outcomes from a peer-review chart rounds conference. We also provide...